Comparison of Helicobacter pylori eradication rates between 7 and 14 days of tailored therapy according to clarithromycin resistance test: a randomized, multicenter, non-inferiority study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006574

Enrollment

314

Registered

2021-09-10

Start date

2021-08-25

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Patients are randomly allocated to receive a 7- or 14-days standard triple therapy (rabeprazole 20mg, amoxicillin 1.0g, clarithromycin 500mg, each administered twice daily for 7 days or 14 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Persons who needs to receive Helicobacter pylori test ? No history of H. pylori treatment ? No history of antibiotics use within 1 month ? Persons who agree to the study process and goal

Exclusion criteria

Exclusion criteria: ? Recent antibiotics use within 1 month ? Person who received subtotal gastrectomy ? Person who has a severe hepatic, renal, and cardiopulmonary abnormality ? Person who do not agree to attend this study

Design outcomes

Primary

Measure	Time frame
Eradication success rate	—

Secondary

Measure	Time frame
Side effect rate/Compliance	—

Countries

Korea, Republic of

Contacts

Public ContactKyoungwon Jung

Kosin University Gospel Hospital

forjkw@gmail.com+82-51-990-6103

Outcome results